Overview

A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and Valsartan

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

A randomized, open-label, single dosing, two-way crossover clinical trial to compare the safety/tolerability and pharmacokinetics of the combination of Cilnidipine 10mg and Valsartan 160mg in comparison to each component coadministered in healthy male volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

IlDong Pharmaceutical Co Ltd

Treatments:

Cilnidipine
Valsartan